EMD-22718
nsEM map of the 16055 SOSIP HIV Env trimer in complex with polyclonal Fab from rabbit r2467
EMD-22718
Single-particle17.2 Å

Map released: 16/12/2020
Last modified: 10/03/2021
Sample Organism:
synthetic construct
Sample: nsEM map of the 16055 SOSIP HIV Env trimer in complex with polyclonal Fab from rabbit r2467 (Week 22)
Deposition Authors: Ward AB, Antanasijevic A
Sample: nsEM map of the 16055 SOSIP HIV Env trimer in complex with polyclonal Fab from rabbit r2467 (Week 22)
Deposition Authors: Ward AB, Antanasijevic A
Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles.
Brouwer PJM,
Antanasijevic A,
de Gast M
,
Allen JD
,
Bijl TPL,
Yasmeen A,
Ravichandran R,
Burger JA,
Ozorowski G
,
Torres JL
,
LaBranche C
,
Montefiori DC,
Ringe RP,
van Gils MJ
,
Moore JP,
Klasse PJ,
Crispin M
,
King NP,
Ward AB
,
Sanders RW
(2021) Npj Vaccines , 6 , 24 - 24









(2021) Npj Vaccines , 6 , 24 - 24
Abstract:
The HIV-1 envelope glycoprotein trimer is poorly immunogenic because it is covered by a dense glycan shield. As a result, recombinant Env glycoproteins generally elicit inadequate antibody levels that neutralize clinically relevant, neutralization-resistant (Tier-2) HIV-1 strains. Multivalent antigen presentation on nanoparticles is an established strategy to increase vaccine-driven immune responses. However, due to nanoparticle instability in vivo, the display of non-native Env structures, and the inaccessibility of many neutralizing antibody (NAb) epitopes, the effects of nanoparticle display are generally modest for Env trimers. Here, we generate two-component self-assembling protein nanoparticles presenting twenty SOSIP trimers of the clade C Tier-2 genotype 16055. We show in a rabbit immunization study that these nanoparticles induce 60-fold higher autologous Tier-2 NAb titers than the corresponding SOSIP trimers. Epitope mapping studies reveal that the presentation of 16055 SOSIP trimers on these nanoparticle focuses antibody responses to an immunodominant apical epitope. Thus, these nanoparticles are a promising platform to improve the immunogenicity of Env trimers with apex-proximate NAb epitopes.
The HIV-1 envelope glycoprotein trimer is poorly immunogenic because it is covered by a dense glycan shield. As a result, recombinant Env glycoproteins generally elicit inadequate antibody levels that neutralize clinically relevant, neutralization-resistant (Tier-2) HIV-1 strains. Multivalent antigen presentation on nanoparticles is an established strategy to increase vaccine-driven immune responses. However, due to nanoparticle instability in vivo, the display of non-native Env structures, and the inaccessibility of many neutralizing antibody (NAb) epitopes, the effects of nanoparticle display are generally modest for Env trimers. Here, we generate two-component self-assembling protein nanoparticles presenting twenty SOSIP trimers of the clade C Tier-2 genotype 16055. We show in a rabbit immunization study that these nanoparticles induce 60-fold higher autologous Tier-2 NAb titers than the corresponding SOSIP trimers. Epitope mapping studies reveal that the presentation of 16055 SOSIP trimers on these nanoparticle focuses antibody responses to an immunodominant apical epitope. Thus, these nanoparticles are a promising platform to improve the immunogenicity of Env trimers with apex-proximate NAb epitopes.